Ticagrelor 90 Mg

Manufacturer: Sunlife

TICAGRELOR TABLETS 90 MG

Product Code: GMP0653

STRIP OF 14 TAB

MRP: ~~₹ 360.00~~ (Inclusive of all taxes)

₹ 199.00 ( 44.72% Off )

Prescription required for purchase. Our doctors will review and verify it before confirming your order. Add to cart and submit your prescription with ease.

Share Product

Product Details

TICAGRELOR TABLETS 90 MG

Below are the product's comprehensive details, including its indications, administration, storage, side effects, safety advice, references, mechanism of action, and therapeutic uses.

Ticagrelor 90mg tablet is used along with low-dose aspirin to help prevent heart attack and stroke in people with a history of heart disease, stroke, or at increased risk for heart disease or stroke (for example, due to diabetes, history of transient isch

Take this medicine at the same time every day. You may take it with or without food.

Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing. Keep out of the reach of children.

Back pain; bleeding gums; blurred vision; chest pain, tightness, or discomfort; confusion; cough; dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position;headache; increased menstrual flow or vaginal bleeding, un

Evidence has demonstrated fetal abnormalities or risks when used during pregnancy Evidence and/or expert consensus has demonstrated harmful infant effects when used during breastfeeding.

Tell your doctor right away if you have chest tightness, or difficult or trouble breathing when asleep or awake. While you are using this medicine, if you have any kind of bleeding, it may take longer than usual to stop, especially if you hurt yourself.

Product Information: BRILINTA(TM) oral tablets, ticagrelor oral tablets. AstraZeneca LP (per manufacturer), Wilmington, DE, 2011. Li J, Tang W, Storey RF, et al: Population pharmacokinetics of ticagrelor in patients with acute coronary syndromes. Int J C

Ticagrelor, a cyclopentyltriazolopyrimidine, and its equipotent metabolite (AR-C124910XX) reversibly interact with the platelet P2Y(12) ADP-receptor, thereby preventing signal transduction and platelet activation and aggregation

Platelet Aggregation Inhibitor

Disclaimer

At Genericart, our primary goal is to provide information that is thoroughly reviewed, accurate, and reliable. However, it is important to note that the content provided here should not be considered a substitute for professional medical advice. The information presented on our platform is intended for educational purposes only and may not cover all aspects of specific health conditions, medications, potential side effects, drug interactions, warnings, or alerts. We strongly encourage consulting with a qualified healthcare professional for advice and guidance regarding their health concerns and medication needs.